Thymic carcinoma: 30 cases at a single institution

Area of Science:

• Oncology
• Thoracic Surgery
• Medical Research

Background:

• Thymic carcinoma is a rare, aggressive mediastinal neoplasm with variable prognosis.
• Standardized prognostic factors and treatments for thymic carcinoma remain undefined.

Purpose of the Study:

• To retrospectively analyze clinical and pathological data of thymic carcinoma patients.
• To identify significant prognostic factors influencing survival in thymic carcinoma.

Main Methods:

• Retrospective review of 30 thymic carcinoma patients treated at Nagoya City University Hospital.
• Analysis of treatment modalities including chemotherapy, chemoradiotherapy, and surgical resection (total/subtotal).
• Evaluation of prognostic significance of resectability, metastasis type, and treatment approach.

Main Results:

• Resectability was the sole significant prognostic factor identified via multivariate analysis (hazard ratio 5.123).
• Total resection offered a significantly better prognosis than subtotal resection and inoperable cases.
• Hematogenous metastasis predicted a poorer prognosis, while lymphogenous metastasis did not.

Conclusions:

• Resectability is the most critical prognostic factor in thymic carcinoma.
• Accurate pre-operative staging to identify unresectable Masaoka stage IVb disease is crucial.
• Neoadjuvant chemotherapy or chemoradiotherapy may improve resectability and patient outcomes.